Your browser doesn't support javascript.
loading
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Copland, Emma; Canoy, Dexter; Nazarzadeh, Milad; Bidel, Zeinab; Ramakrishnan, Rema; Woodward, Mark; Chalmers, John; Teo, Koon K; Pepine, Carl J; Davis, Barry R; Kjeldsen, Sverre; Sundström, Johan; Rahimi, Kazem.
Afiliação
  • Copland E; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK; National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Canoy D; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK; National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Nazarzadeh M; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
  • Bidel Z; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK; National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Ramakrishnan R; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
  • Woodward M; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Department of Epidemiology and Biostatistics, The George Institute for Global Health, Imperial College London, London, UK; Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
  • Chalmers J; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
  • Teo KK; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada.
  • Pepine CJ; College of Medicine, University of Florida, Gainesville, FL, USA.
  • Davis BR; School of Public Health, University of Texas, Houston, TX, USA.
  • Kjeldsen S; Department of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway.
  • Sundström J; Department of Medical Sciences, Clinical Epidemiology, Uppsala University, Uppsala, Sweden.
  • Rahimi K; Deep Medicine, Oxford Martin School, University of Oxford, Oxford, UK; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK; National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Ele
Lancet Oncol ; 22(4): 558-570, 2021 04.
Article em En | MEDLINE | ID: mdl-33794209

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão / Neoplasias / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão / Neoplasias / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido